Use of whole genome sequencing to identify low-frequency mutations in SARS-CoV-2 patients treated with remdesivir
Description
CONCLUSIONS: Minimal intra-host variability and stochastic low-frequency variants detected in moderately ill patients suggests little selective pressure in patients receiving short courses of RDV. The barrier to RDV resistance is high in patients
